Skin Elements Requests Trading Halt for Capital Raise
Key points
- Skin Elements (ASX: SKN) requests trading halt pending announcement of capital raise
- Trading halt to remain in place until earlier of announcement or market open on 15 October 2025
- Company not aware of any other information necessary to inform the market
Full summary
Skin Elements Limited (ASX: SKN), an Australian owned and operated biotechnology healthcare company, has requested a trading halt in its securities with immediate effect. The trading halt has been requested pending an announcement by the company regarding a capital raise. In accordance with ASX Listing Rule 17.1, Skin Elements has stated that the trading halt will remain in place until the earlier of the making of an announcement or the commencement of trading on Wednesday, 15 October 2025. The company has confirmed that it is not aware of any other information necessary to inform the market about the trading halt, and that it is not aware of any reason why the trading halt should not be granted. The announcement has been authorised by the Board of Skin Elements Limited.
Summary generated by a large language model. Please interpret with care.